Microbial keratitis following intracorneal ring segment implantation.
Chalasani
R
R
Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Beltz
J
J
Jhanji
V
V
Vajpayee
R B
RB
D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D020878:Device Removal; D005260:Female; D006801:Humans; D007634:Keratitis / Q000209:etiology* / Q000382:microbiology; D007640:Keratoconus / Q000601:surgery*; D019904:Polymethyl Methacrylate; D019736:Prostheses and Implants / Q000009:adverse effects* / Q000382:microbiology; D019919:Prosthesis Implantation / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000382:microbiology*; D013212:Staphylococcus epidermidis / Q000302:isolation & purification; D014031:Tobramycin / Q000008:administration & dosage; D014640:Vancomycin / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D019904:Polymethyl Methacrylate; D014031:Tobramycin